Cannabix Technologies Inc. is a technology company focused on the development, manufacturing and commercialization of cannabis breathalyzer devices designed to detect recent use of tetrahydrocannabinol (THC), the primary psychoactive component in cannabis. Founded and incorporated in British Columbia, Canada, the company leverages proprietary sensor technology and advanced analytics to address the growing demand for rapid, non-invasive roadside and workplace testing solutions. Through continuous research and development, Cannabix Technologies aims to offer a reliable tool for law enforcement agencies, regulatory bodies and private enterprises seeking to ensure public safety in jurisdictions where cannabis legalization and regulation are evolving.
The company’s flagship product, the Cannabix Cannabis Breathalyzer, utilizes a combination of nanotechnology and electrochemical sensing to detect minute traces of THC in exhaled breath. In laboratory and field trials, the device has undergone multiple validation stages to establish sensitivity and selectivity parameters. Cannabix has partnered with independent testing laboratories in North America to refine its algorithms and calibration methods, with ongoing efforts to meet international standards for performance and accuracy. These activities position the company at the forefront of emerging roadside screening technology for cannabis impairment.
While initially targeting law enforcement applications in Canada, the United States and select European markets, Cannabix Technologies is also exploring broader applications in workplace safety and clinical environments. The company envisions its breathalyzer being deployed in industrial sites, transportation hubs and rehabilitation centers where rapid and objective testing for recent cannabis use is critical. Cannabix is actively engaging with regulatory authorities and potential end users to define testing protocols, training programs and deployment strategies that align with regional legal frameworks and operational requirements.
Leadership at Cannabix Technologies is headed by Chief Executive Officer Ken Knapton, who brings decades of experience in technology commercialization and regulatory affairs. Under his guidance, the company has navigated multiple development milestones and maintained a focus on product validation, intellectual property protection and strategic partnerships. Looking ahead, Cannabix continues to expand its intellectual property portfolio, advance its regulatory filings and prepare for pilot deployments of its breathalyzer devices. The company’s ongoing commitment to innovation aims to address the critical need for reliable, on-site cannabis impairment testing amid shifting legal and social landscapes.
AI Generated. May Contain Errors.
